Intracytoplasmic Sperm Injection (ICSI) is an assisted reproductive technique (ART) initially developed by Dr. Gianpiero D. Palermo in 1993 to treat male infertility. It is most commonly used in conjunction with in vitro fertilization (IVF) or a less commonly used technique called zygote intrafallopian transfer (ZIFT). In natural fertilization, the sperm must penetrate the surface of the female egg, or oocyte. When the male has a fertility problem such as low sperm count, malformed sperm shape, or sperm immobility, there is a significant decrease in the chance a healthy sperm will penetrate the outer surface of the oocyte. Other fertility problems ICSI can be used to overcome include the sperm having trouble attaching to the egg or the male having a blockage in his reproductive tract preventing normal ejaculation. In this procedure, the physician first obtains the sperm and oocytes from the male and female and then manually injects the sperm through a needle into the oocyte to fertilize it in an injection plate. The physician then places the fertilized egg into the female s uterus for implantation, following IVF procedures.

Alan Osborne Trounson is a scientist from Australia who studies embryology and stem cells. His research has improved the success rates of in vitro fertilization, or IVF. IVF is a medical procedure in which scientists fertilize an egg cell with sperm outside of the body, often in a laboratory petri dish, then transfer the fertilized egg to a woman’s uterus to start pregnancy. Trounson also researched embryonic stem cells, or stem cells collected from embryos, and their potential for treating injuries and diseases. Additionally, Trounson led the Californian Institute for Regenerative Medicine, or CIRM, one of the largest agencies to fund stem cell research in California, from 2007 to 2014. Over the course of his career, Trounson developed several techniques that improved the effectiveness of IVF, including fertility treatments and cryopreservation, and supported stem cell research as a scientist and administrator.

In December of 2016, Margus Punab and colleagues published “Causes of Male Infertility: A 9-year Prospective Monocentre Study on 1737 Patients with Reduced Total Sperm Counts,” hereafter “Male Infertility,” in the journal Human Reproduction. The study examines the main causes of severe male factor infertility, or SMF infertility, which occurs when a male’s semen has a very low number of healthy sperm cells or contains atypically low levels of sperm cells. In “Male Infertility,” the authors determine the primary cause of SMF infertility in forty percent of their participants, and among those participants, they found that the primary causes of SMF infertility were varicoceles, or enlarged veins within the loose bag of skin holding the testicles. The authors did not determine the cause of SMF infertility in the remaining sixty percent of the cases, noting a gap in the current understanding of the causes of SMF infertility. “Male Infertility” was one of the first large-scale studies to reveal certain underlying causes of SMF infertility, and its conclusions have allowed researchers to investigate fertility solutions for male patients who would otherwise not be able to reproduce.